Teriparatide therapy for bisphosphonate-associated osteonecrosis of the jaw in an elderly japanese woman with severe osteoporosis

Jun Iwamoto, Kaori Yago, Yoshihiro Sato, Hideo Matsumoto

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

We report on the case of a severely osteoporotic elderly Japanese woman with bisphosphonate-associated osteonecrosis of the jaw (ONJ), who was treated successfully with teriparatide. A 79-year-old woman with severe osteoporosis and bisphosphonate-associated ONJ was treated with teriparatide after debridement of the necrotic tissue in the jaw bone. Computed tomography (CT) images revealed the bone defect in the mandible after debridement of the necrotic tissue associated with ONJ. According to the attending dentist, the ONJ healed after 2 months of therapy. After 3 months of treatment, a robust increase in the serum level of the bone formation marker, serum intact procollagen type 1 N-terminal propeptide, was noted and a repeat CT revealed improvement of the bone defect of the mandible. These results suggest the beneficial effects of teriparatide therapy in the severely osteoporotic elderly woman with ONJ.

Original languageEnglish
Pages (from-to)547-553
Number of pages7
JournalClinical Drug Investigation
Volume32
Issue number8
DOIs
Publication statusPublished - 2012

Fingerprint

Bisphosphonate-Associated Osteonecrosis of the Jaw
Teriparatide
Jaw
Osteoporosis
Osteonecrosis
Debridement
Mandible
Bone and Bones
Tomography
Therapeutics
Collagen Type I
Dentists
Osteogenesis
Biomarkers
Serum

Keywords

  • bisphosphonate
  • elderly
  • osteonecrosis of the jaw
  • osteoporosis
  • teriparatide

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Teriparatide therapy for bisphosphonate-associated osteonecrosis of the jaw in an elderly japanese woman with severe osteoporosis. / Iwamoto, Jun; Yago, Kaori; Sato, Yoshihiro; Matsumoto, Hideo.

In: Clinical Drug Investigation, Vol. 32, No. 8, 2012, p. 547-553.

Research output: Contribution to journalArticle

Iwamoto, Jun ; Yago, Kaori ; Sato, Yoshihiro ; Matsumoto, Hideo. / Teriparatide therapy for bisphosphonate-associated osteonecrosis of the jaw in an elderly japanese woman with severe osteoporosis. In: Clinical Drug Investigation. 2012 ; Vol. 32, No. 8. pp. 547-553.
@article{efb584e2cae445478b24b034f0376ad7,
title = "Teriparatide therapy for bisphosphonate-associated osteonecrosis of the jaw in an elderly japanese woman with severe osteoporosis",
abstract = "We report on the case of a severely osteoporotic elderly Japanese woman with bisphosphonate-associated osteonecrosis of the jaw (ONJ), who was treated successfully with teriparatide. A 79-year-old woman with severe osteoporosis and bisphosphonate-associated ONJ was treated with teriparatide after debridement of the necrotic tissue in the jaw bone. Computed tomography (CT) images revealed the bone defect in the mandible after debridement of the necrotic tissue associated with ONJ. According to the attending dentist, the ONJ healed after 2 months of therapy. After 3 months of treatment, a robust increase in the serum level of the bone formation marker, serum intact procollagen type 1 N-terminal propeptide, was noted and a repeat CT revealed improvement of the bone defect of the mandible. These results suggest the beneficial effects of teriparatide therapy in the severely osteoporotic elderly woman with ONJ.",
keywords = "bisphosphonate, elderly, osteonecrosis of the jaw, osteoporosis, teriparatide",
author = "Jun Iwamoto and Kaori Yago and Yoshihiro Sato and Hideo Matsumoto",
year = "2012",
doi = "10.2165/11634430",
language = "English",
volume = "32",
pages = "547--553",
journal = "Clinical Drug Investigation",
issn = "1173-2563",
publisher = "Adis International Ltd",
number = "8",

}

TY - JOUR

T1 - Teriparatide therapy for bisphosphonate-associated osteonecrosis of the jaw in an elderly japanese woman with severe osteoporosis

AU - Iwamoto, Jun

AU - Yago, Kaori

AU - Sato, Yoshihiro

AU - Matsumoto, Hideo

PY - 2012

Y1 - 2012

N2 - We report on the case of a severely osteoporotic elderly Japanese woman with bisphosphonate-associated osteonecrosis of the jaw (ONJ), who was treated successfully with teriparatide. A 79-year-old woman with severe osteoporosis and bisphosphonate-associated ONJ was treated with teriparatide after debridement of the necrotic tissue in the jaw bone. Computed tomography (CT) images revealed the bone defect in the mandible after debridement of the necrotic tissue associated with ONJ. According to the attending dentist, the ONJ healed after 2 months of therapy. After 3 months of treatment, a robust increase in the serum level of the bone formation marker, serum intact procollagen type 1 N-terminal propeptide, was noted and a repeat CT revealed improvement of the bone defect of the mandible. These results suggest the beneficial effects of teriparatide therapy in the severely osteoporotic elderly woman with ONJ.

AB - We report on the case of a severely osteoporotic elderly Japanese woman with bisphosphonate-associated osteonecrosis of the jaw (ONJ), who was treated successfully with teriparatide. A 79-year-old woman with severe osteoporosis and bisphosphonate-associated ONJ was treated with teriparatide after debridement of the necrotic tissue in the jaw bone. Computed tomography (CT) images revealed the bone defect in the mandible after debridement of the necrotic tissue associated with ONJ. According to the attending dentist, the ONJ healed after 2 months of therapy. After 3 months of treatment, a robust increase in the serum level of the bone formation marker, serum intact procollagen type 1 N-terminal propeptide, was noted and a repeat CT revealed improvement of the bone defect of the mandible. These results suggest the beneficial effects of teriparatide therapy in the severely osteoporotic elderly woman with ONJ.

KW - bisphosphonate

KW - elderly

KW - osteonecrosis of the jaw

KW - osteoporosis

KW - teriparatide

UR - http://www.scopus.com/inward/record.url?scp=84863594102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863594102&partnerID=8YFLogxK

U2 - 10.2165/11634430

DO - 10.2165/11634430

M3 - Article

VL - 32

SP - 547

EP - 553

JO - Clinical Drug Investigation

JF - Clinical Drug Investigation

SN - 1173-2563

IS - 8

ER -